When less is better - Differentiated therapies to safely achieve TR 0-1+
Sponsored by Edwards Lifesciences
Tricuspid valve repair/replacement
Simulation-based Symposium
Edwards Lifesciences
Theatre Havane - Simulation Learning Room
Watch this session if you want
To understand the benefit of a tricuspid portfolio to treat a wide range of tricuspid regurgitation patients
To discuss the importance of achieving optimal tricuspid regurgitation reduction to 1+ or less to impact patients' prognosis
To discover how the clover technique in tricuspid TEER can help you acheive optimal tricuspid regurgitation reduction in an evidence, simulation, and case-based discussion
To discuss the key PASCAL features that allow for optimal outcomes
To explore how EVOQUE provides a safe and effective treatment option for tricuspid regurgitation patients












